In all three tested breast cancer cell lines, AQP5 overexpression did not activate the PI3K/AKT signaling pathway, as evidenced by the lack of an increase in phosphorylated AKT or the pAKT/AKT ratio (Figure 5A–C). This evidence concerns the gene AQP5 and breast carcinoma.